应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09966 康宁杰瑞制药-B
休市中 09-05 16:08:27
10.330
+0.880
+9.31%
最高
10.580
最低
9.340
成交量
649.80万
今开
9.600
昨收
9.450
日振幅
13.12%
总市值
100.30亿
流通市值
100.30亿
总股本
9.71亿
成交额
6,566万
换手率
0.67%
流通股本
9.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 康宁杰瑞制药-B 09月05日卖空量成交3.1万股,卖空比例为0.48%
市场透视 · 09-05 08:30
每日卖空追踪 | 康宁杰瑞制药-B 09月05日卖空量成交3.1万股,卖空比例为0.48%
每日卖空追踪 | 康宁杰瑞制药-B 09月01日卖空量成交10.8万股,卖空比例为2.38%
市场透视 · 09-01
每日卖空追踪 | 康宁杰瑞制药-B 09月01日卖空量成交10.8万股,卖空比例为2.38%
异动解读 | 康宁杰瑞制药-B盘中大涨8.86%,中期业绩扭亏为盈
异动解读 · 09-01
异动解读 | 康宁杰瑞制药-B盘中大涨8.86%,中期业绩扭亏为盈
异动解读 | 康宁杰瑞制药-B中期业绩扭亏为盈,盘中大涨8.86%
异动解读 · 09-01
异动解读 | 康宁杰瑞制药-B中期业绩扭亏为盈,盘中大涨8.86%
港股异动 | 康宁杰瑞制药-B(09966)盘中拉升逾8% 中期公司期内溢利2157.5万元 研发开支增加
智通财经 · 09-01
港股异动 | 康宁杰瑞制药-B(09966)盘中拉升逾8% 中期公司期内溢利2157.5万元 研发开支增加
每日卖空追踪 | 康宁杰瑞制药-B 08月29日卖空量成交7.3万股,卖空比例为2.2%
市场透视 · 08-29
每日卖空追踪 | 康宁杰瑞制药-B 08月29日卖空量成交7.3万股,卖空比例为2.2%
异动解读 | 康宁杰瑞制药-B盘中大涨5.03%,中期业绩亏转盈
异动解读 · 08-29
异动解读 | 康宁杰瑞制药-B盘中大涨5.03%,中期业绩亏转盈
异动解读 | 康宁杰瑞制药-B发布亮眼中期业绩,股价盘中大涨5.03%
异动解读 · 08-29
异动解读 | 康宁杰瑞制药-B发布亮眼中期业绩,股价盘中大涨5.03%
康宁杰瑞制药-B(09966)发布中期业绩 期内溢利2157.5万元 同比扭亏为盈
智通财经 · 08-28
康宁杰瑞制药-B(09966)发布中期业绩 期内溢利2157.5万元 同比扭亏为盈
康宁杰瑞制药-B盘中异动 下午盘快速跳水5.08%
市场透视 · 08-27
康宁杰瑞制药-B盘中异动 下午盘快速跳水5.08%
每日卖空追踪 | 康宁杰瑞制药-B 08月25日卖空量成交18.4万股,卖空比例为2.88%
市场透视 · 08-25
每日卖空追踪 | 康宁杰瑞制药-B 08月25日卖空量成交18.4万股,卖空比例为2.88%
港股异动 | 康宁杰瑞制药-B(09966)涨幅扩大逾15% 下周四将发中期业绩 预计扭亏为盈至不少于2000万元
智通财经 · 08-22
港股异动 | 康宁杰瑞制药-B(09966)涨幅扩大逾15% 下周四将发中期业绩 预计扭亏为盈至不少于2000万元
生物医药B类股多数上行,基石药业涨超10%,永康生物涨超6%
老虎资讯综合 · 08-21
生物医药B类股多数上行,基石药业涨超10%,永康生物涨超6%
港股异动 | 康宁杰瑞制药-B(09966)再涨超7% 本月底将发中期业绩 预计上半年利润不少于2000万元
智通财经 · 08-18
港股异动 | 康宁杰瑞制药-B(09966)再涨超7% 本月底将发中期业绩 预计上半年利润不少于2000万元
港股异动 | 康宁杰瑞制药-B(09966.HK)盈喜后涨超3% 预计中期利润不少于2000万元
智通财经 · 08-14
港股异动 | 康宁杰瑞制药-B(09966.HK)盈喜后涨超3% 预计中期利润不少于2000万元
康宁杰瑞制药-B(09966)发盈喜 预计中期利润不少于2000万元
智通财经 · 08-13
康宁杰瑞制药-B(09966)发盈喜 预计中期利润不少于2000万元
每日卖空追踪 | 康宁杰瑞制药-B 08月11日卖空量成交2万股,卖空比例为1.85%
市场透视 · 08-11
每日卖空追踪 | 康宁杰瑞制药-B 08月11日卖空量成交2万股,卖空比例为1.85%
康宁杰瑞制药-B与苏州康宁杰瑞订立一份技术开发合同
新浪港股 · 08-11
康宁杰瑞制药-B与苏州康宁杰瑞订立一份技术开发合同
康宁杰瑞制药-B(09966)与苏州康宁杰瑞订立一份技术开发合同
智通财经 · 08-08
康宁杰瑞制药-B(09966)与苏州康宁杰瑞订立一份技术开发合同
每日卖空追踪 | 康宁杰瑞制药-B 08月08日卖空量成交4.1万股,卖空比例为3.12%
市场透视 · 08-08
每日卖空追踪 | 康宁杰瑞制药-B 08月08日卖空量成交4.1万股,卖空比例为3.12%
加载更多
公司概况
公司名称:
康宁杰瑞制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司高度差异化的内部管线由处于不同研发阶段的肿瘤单克隆抗体、双特异性抗体及ADCs组成。该公司的候选药物包括KN046(PD-L1/CTLA-4双特异性抗体), KN026(HER2/HER2双特异性抗体), KN035(皮下注射PD-L1), JSKN003(HER2双表位ADC)等,用于1L胰脏癌、1L乳腺癌、晚期实体瘤、HER2表达实体瘤等适应症。
发行价格:
--
{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":10.33,"timestamp":1757059707008,"preClose":9.45,"halted":0,"volume":6498000,"delay":0,"floatShares":971000000,"shares":971000000,"eps":0.1890820860718045,"marketStatus":"休市中","change":0.88,"latestTime":"09-05 16:08:27","open":9.6,"high":10.58,"low":9.34,"amount":65661559,"amplitude":0.131217,"askPrice":10.33,"askSize":11000,"bidPrice":10.31,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.25844627482165833,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1757295000000},"marketStatusCode":7,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":9.45,"openAndCloseTimeList":[[1757035800000,1757044800000],[1757048400000,1757059200000]],"volumeRatio":1.6344936209051104,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"2565567162","title":"每日卖空追踪 | 康宁杰瑞制药-B 09月05日卖空量成交3.1万股,卖空比例为0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565567162","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565567162?lang=zh_cn&edition=full","pubTime":"2025-09-05 16:30","pubTimestamp":1757061041,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间09月05日,涨9.31%,卖空量成交3.1万股%,较上一交易日减少90.46%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905172824a71194c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905172824a71194c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2564840109","title":"每日卖空追踪 | 康宁杰瑞制药-B 09月01日卖空量成交10.8万股,卖空比例为2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564840109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564840109?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:30","pubTimestamp":1756715441,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间09月01日,涨6.05%,卖空量成交10.8万股%,较上一交易日持平更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173850a4ad2402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173850a4ad2402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"1140034095","title":"异动解读 | 康宁杰瑞制药-B盘中大涨8.86%,中期业绩扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1140034095","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140034095?lang=zh_cn&edition=full","pubTime":"2025-09-01 10:54","pubTimestamp":1756695282,"startTime":"0","endTime":"0","summary":"周一盘中,康宁杰瑞制药-B股价大幅上涨,截至发稿时涨幅达8.86%,报10.08港元。该股成交额达1819.5万港元,显示投资者对公司近期发布的中期业绩报告反应积极。根据公司8月28日发布的2025年上半年业绩报告,康宁杰瑞制药-B实现营收3.19亿元人民币,同比增长84.05%。更值得注意的是,公司扭亏为盈,期内溢利达2157.5万元人民币,而去年同期亏损4489.6万元。2025年上半年研发开支达到253.2百万元人民币,较2024年同期的194.5百万元增加了58.7百万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09966"],"gpt_icon":0},{"id":"1144108480","title":"异动解读 | 康宁杰瑞制药-B中期业绩扭亏为盈,盘中大涨8.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144108480","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144108480?lang=zh_cn&edition=full","pubTime":"2025-09-01 10:54","pubTimestamp":1756695280,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B今日盘中大涨8.86%,报10.08港元,成交额1819.5万港元,引起市场广泛关注。消息面上,康宁杰瑞制药-B于8月28日发布了截至2025年6月30日止的中期业绩报告,显示公司财务状况显著改善。公告显示,截至2025年6月30日止六个月,公司研发开支达到253.2百万元人民币,较上年同期的194.5百万元增加了58.7百万元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09966"],"gpt_icon":1},{"id":"2564929862","title":"港股异动 | 康宁杰瑞制药-B(09966)盘中拉升逾8% 中期公司期内溢利2157.5万元 研发开支增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2564929862","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564929862?lang=zh_cn&edition=full","pubTime":"2025-09-01 10:51","pubTimestamp":1756695081,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康宁杰瑞制药-B盘中拉升逾8%,截至发稿,涨8.86%,报10.08港元,成交额1819.5万港元。消息面上,8月28日,康宁杰瑞制药-B发布截至2025年6月30日止六个月中期业绩,收入3.19亿元,同比增加84.05%;期内溢利2157.5万元,上年同期亏损4489.6万元,同比扭亏为盈;每股基本盈利0.02元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1339762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2563302274","title":"每日卖空追踪 | 康宁杰瑞制药-B 08月29日卖空量成交7.3万股,卖空比例为2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563302274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563302274?lang=zh_cn&edition=full","pubTime":"2025-08-29 16:30","pubTimestamp":1756456244,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间08月29日,涨1.31%,卖空量成交7.3万股%,较上一交易日减少7.59%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829174637a4a76b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829174637a4a76b3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"1157614122","title":"异动解读 | 康宁杰瑞制药-B盘中大涨5.03%,中期业绩亏转盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1157614122","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157614122?lang=zh_cn&edition=full","pubTime":"2025-08-29 13:15","pubTimestamp":1756444530,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(09966)今日盘中大涨5.03%,引起市场广泛关注。\n\n消息面上,康宁杰瑞制药-B公布了截至2025年6月30日止的中期业绩报告,显示公司成功实现扭亏为盈,这一利好消息推动了股价的上涨。\n\n根据公告,康宁杰瑞制药-B在2025年上半年实现营业额3.19亿元人民币,同比增长84%。公司扭亏为盈,实现股东应占溢利2157.5万元人民币,而去年同期亏损4489.6万元人民币。每股盈利为0.02元人民币。尽管业绩向好,公司决定本期不派息。这些积极的财务指标显示了公司经营状况的显著改善,增强了投资者对其未来发展的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09966"],"gpt_icon":0},{"id":"1165652548","title":"异动解读 | 康宁杰瑞制药-B发布亮眼中期业绩,股价盘中大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165652548","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165652548?lang=zh_cn&edition=full","pubTime":"2025-08-29 13:14","pubTimestamp":1756444473,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B今日盘中大涨5.03%,引发市场关注。这一显著涨幅主要得益于公司发布的强劲中期业绩报告。根据康宁杰瑞制药-B公布的截至2025年6月30日的中期业绩,公司成功实现扭亏为盈。这一亮眼的业绩表现无疑增强了投资者对康宁杰瑞制药-B未来发展的信心。作为一家生物制药公司,康宁杰瑞制药-B的这一业绩改善可能预示着其研发投入开始获得回报,或核心业务正在步入快速增长轨道。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09966"],"gpt_icon":0},{"id":"2562161037","title":"康宁杰瑞制药-B(09966)发布中期业绩 期内溢利2157.5万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2562161037","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562161037?lang=zh_cn&edition=full","pubTime":"2025-08-28 20:59","pubTimestamp":1756385959,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布截至2025年6月30日止六个月中期业绩,收入3.19亿元(人民币,下同),同比增加84.05%;期内溢利2157.5万元,上年同期亏损4489.6万元,同比扭亏为盈;每股基本盈利0.02元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1337712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B(09966)发布中期业绩 期内溢利2157.5万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2562718569","title":"康宁杰瑞制药-B盘中异动 下午盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562718569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562718569?lang=zh_cn&edition=full","pubTime":"2025-08-27 14:30","pubTimestamp":1756276244,"startTime":"0","endTime":"0","summary":"2025年08月27日下午盘14时30分,康宁杰瑞制药-B股票出现波动,股价急速下挫5.08%。截至发稿,该股报9.720港元/股,成交量279.7万股,换手率0.29%,振幅8.11%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为4.09%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司高度差异化的内部管线由处于不同研发阶段的肿瘤单克隆抗体、双特异性抗体及ADCs组成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827143044a6fe4b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827143044a6fe4b8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2562834477","title":"每日卖空追踪 | 康宁杰瑞制药-B 08月25日卖空量成交18.4万股,卖空比例为2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562834477","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562834477?lang=zh_cn&edition=full","pubTime":"2025-08-25 16:30","pubTimestamp":1756110646,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间08月25日,涨1.67%,卖空量成交18.4万股%,较上一交易日减少33.57%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825174415a49d6a87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825174415a49d6a87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2561290734","title":"港股异动 | 康宁杰瑞制药-B(09966)涨幅扩大逾15% 下周四将发中期业绩 预计扭亏为盈至不少于2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561290734","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561290734?lang=zh_cn&edition=full","pubTime":"2025-08-22 15:51","pubTimestamp":1755849102,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康宁杰瑞制药-B尾盘涨幅进一步扩大,截至发稿,涨14.03%,报10.81港元,成交额7386.46万港元。消息面上,康宁杰瑞制药将于8月28日(下周四)召开董事会会议以审批中期业绩。公司此前预计,上半年取得利润不少于人民币2000万元,去年同期亏损约人民币4490万元。公司计划开展用于治疗晚期恶性实体瘤的JSKN022首次人体临床研究。目前全球范围内尚无靶向整合素αvβ6或PD-L1的ADC上市,相关在研药物均处于临床研究阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 康宁杰瑞制药-B(09966)涨幅扩大逾15% 下周四将发中期业绩 预计扭亏为盈至不少于2000万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"1159678901","title":"生物医药B类股多数上行,基石药业涨超10%,永康生物涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159678901","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159678901?lang=zh_cn&edition=full","pubTime":"2025-08-21 10:30","pubTimestamp":1755743413,"startTime":"0","endTime":"0","summary":"8月21日(周四),港股$生物(000504)$医药B类股多数上行,基石药业涨超10%,永泰生物涨超6%,圣诺医药、$康宁杰瑞(09966)$制药涨超5%,$归创通桥(02190)$涨超3%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2a3e4f84e3af0f1f23efeab215a30c35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","09966","02257","06978"],"gpt_icon":0},{"id":"2560946974","title":"港股异动 | 康宁杰瑞制药-B(09966)再涨超7% 本月底将发中期业绩 预计上半年利润不少于2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560946974","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560946974?lang=zh_cn&edition=full","pubTime":"2025-08-18 14:50","pubTimestamp":1755499845,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康宁杰瑞制药-B再涨超7%,截至发稿,涨6.56%,报9.59港元,成交额3218.92万港元。消息面上,康宁杰瑞制药将于8月28日召开董事会会议以审批中期业绩。公司此前预计,上半年取得利润不少于人民币2000万元,去年同期亏损约人民币4490万元。公司计划开展用于治疗晚期恶性实体瘤的JSKN022首次人体临床研究。目前全球范围内尚无靶向整合素αvβ6或PD-L1的ADC上市,相关在研药物均处于临床研究阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2559935548","title":"港股异动 | 康宁杰瑞制药-B(09966.HK)盈喜后涨超3% 预计中期利润不少于2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559935548","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559935548?lang=zh_cn&edition=full","pubTime":"2025-08-14 10:39","pubTimestamp":1755139195,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2559601230","title":"康宁杰瑞制药-B(09966)发盈喜 预计中期利润不少于2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559601230","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559601230?lang=zh_cn&edition=full","pubTime":"2025-08-13 19:44","pubTimestamp":1755085449,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,预期集团将于截至2025年6月30日止六个月取得利润不少于人民币2000万元,而2024年同期则取得亏损约人民币4490万元。公司于报告期内转亏为盈,主要基于三项授权合作的里程碑收入和商业化产品的销售收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B(09966)发盈喜 预计中期利润不少于2000万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2558657864","title":"每日卖空追踪 | 康宁杰瑞制药-B 08月11日卖空量成交2万股,卖空比例为1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558657864","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558657864?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:30","pubTimestamp":1754901041,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间08月11日,跌1.1%,卖空量成交2万股%,较上一交易日减少86.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172110a6df5369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172110a6df5369&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2558687105","title":"康宁杰瑞制药-B与苏州康宁杰瑞订立一份技术开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2558687105","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558687105?lang=zh_cn&edition=full","pubTime":"2025-08-11 08:33","pubTimestamp":1754872380,"startTime":"0","endTime":"0","summary":" 康宁杰瑞制药-B公布,公司全资附属公司江苏康宁杰瑞生物制药有限公司与苏州康宁杰瑞生物科技有限公司于2025年8月8日订立一份技术开发合同,据此,江苏康宁杰瑞已同意委聘苏州康宁杰瑞提供技术开发服务,而苏州康宁杰瑞将为江苏康宁杰瑞的双特异性抗体偶联药物候选药物进行生产工艺及分析方法开发、进行毒理研究用样品研制及新药临床试验申报临床样品研制,对相关样品进行质量及稳定性研究,并协助进行IND注册申报。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-08-11/doc-infkqfti6097910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK4512","BK4585","09966","BK4148","GLW","BK4588","BK1161","LU0348723411.USD","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2557520472","title":"康宁杰瑞制药-B(09966)与苏州康宁杰瑞订立一份技术开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520472","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520472?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:58","pubTimestamp":1754661524,"startTime":"0","endTime":"0","summary":"苏州康宁杰瑞在与技术开发合同相关的工艺优化服务方面拥有丰富经验和竞争力,且自2018年以来一直为公司可靠的服务供应商。考虑到苏州康宁杰瑞提供相关技术开发服务的品质、将来技术转移的便捷性和保密性,以及就该交易的报价与其他独立第三方供应商相比更具竞争力,公司相信技术开发合同将有助于优化现有的生产及研发工艺,降低相关成本,且会对公司于可见未来产品的研发、制造及IND应用带来积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","BK1574","BK4588","09966","BK4148","BK4512","LU0348723411.USD","GLW","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2557974529","title":"每日卖空追踪 | 康宁杰瑞制药-B 08月08日卖空量成交4.1万股,卖空比例为3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557974529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557974529?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:30","pubTimestamp":1754641840,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间08月08日,涨1.11%,卖空量成交4.1万股%,较上一交易日减少68.7%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180429a6dacf63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180429a6dacf63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":0.1156},{"period":"1month","weight":0.1364},{"period":"3month","weight":0.2961},{"period":"6month","weight":0.7018},{"period":"1year","weight":3.5307},{"period":"ytd","weight":1.9514}],"compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0204},{"period":"3month","weight":0.0683},{"period":"6month","weight":0.049},{"period":"1year","weight":0.4571},{"period":"ytd","weight":0.2671}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司高度差异化的内部管线由处于不同研发阶段的肿瘤单克隆抗体、双特异性抗体及ADCs组成。该公司的候选药物包括KN046(PD-L1/CTLA-4双特异性抗体), KN026(HER2/HER2双特异性抗体), KN035(皮下注射PD-L1), JSKN003(HER2双表位ADC)等,用于1L胰脏癌、1L乳腺癌、晚期实体瘤、HER2表达实体瘤等适应症。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.121729},{"month":2,"riseRate":0.666667,"avgChangeRate":0.22886},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.028638},{"month":4,"riseRate":0.833333,"avgChangeRate":0.061128},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016858},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.029877},{"month":7,"riseRate":0.333333,"avgChangeRate":0.059359},{"month":8,"riseRate":0.333333,"avgChangeRate":0.022561},{"month":9,"riseRate":0.333333,"avgChangeRate":0.097664},{"month":10,"riseRate":0.4,"avgChangeRate":-0.004359},{"month":11,"riseRate":0.6,"avgChangeRate":0.064609},{"month":12,"riseRate":0.6,"avgChangeRate":-0.004095}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}